. 2009 Jun;25(6):345–354. doi: 10.1016/s0828-282x(09)70088-1

TABLE 2.

Risk factor prevalence among Canadian REduction of Atherothrombosis for Continued Health (REACH) Registry patients

	Canada (n=1976)	British Columbia (n=164)	*Prairies^ (n=382)**	Ontario (n=787)	Quebec (n=509)	Maritimes^†(n=134)
Diabetes^‡, %	44.0	49.7	34.9^§	45.7	40.6	61.9^§
Hypertension^¶, %	77.6	85.3^**	71.3^**	80.2^**	77.0	69.9^**
Hypercholesterolemia, %	84.6	88.7	79.5^**	85.4	87.2	83.1
Abdominal obesity^††, %	53.5	48.8	58.9^**	49.0^**	50.3	61.2^**
Overweight/obese (BMI ≥25 kg/m²), %	75.4	75.7	82.0^**	75.1	70.3^**	78.9
Smoking, %
Former^‡‡	44.2	48.3	50.0	43.4	46.3	49.7
Current^§§	13.5	7.5^**	10.7^**	11.9^**	19.6^§	19.0^§
Modified metabolic syndrome^¶¶, %	29.3	21.7^**	26.0	27.6	32.0	39.1^**
Impaired fasting glucose^***, %	22.8	27.2	21.7	22.4	22.5	24.4

The values for hypertension, hypercholesterolemia, abdominal obesity, body mass index (BMI), smoking, modified metabolic syndrome and impaired glucose tolerance are adjusted for age and sex. The overall P-values across the regions were not significant for former smoking and impaired fasting glucose; therefore, no pair-wise comparisons were performed.

Alberta, Manitoba and Saskatchewan;

^†

Newfoundland and Labrador, Prince Edward Island, Nova Scotia and New Brunswick;

^{^‡}

Patients with type 1 or 2 diabetes currently treated with hypoglycemic agents or a history of diabetes;

^{^§}

P<0.001;

^{^¶}

Patients with systolic blood pressure ≥150 mmHg despite therapy for ≥3 months or a history of hypertension;

^**

0.001<P<0.05;

^††

Men: waist circumference ≥102 cm; women: waist circumference ≥88 cm;

^‡‡

≥5 cigarettes/day (mean) >1 month before enrolment;

^§§

≥5 cigarettes/day (mean) within 1 month of enrolment;

^¶¶

Patients with ≥3 of the following: abdominal obesity, triglycerides ≥1.7 mmol/L, blood pressure ≥130/85 mmHg, fasting glucose >6.1 mmol/L;

^***

Patients with fasting glucose >5.6 mmol/L and <7.0 mmol/L